XML 162 R130.htm IDEA: XBRL DOCUMENT v2.4.0.6
Guarantor Financial Information (Condensed Consolidating Statement of Cash Flows) (Details) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Net cash (used in) provided by continuing operating activities $ 1,277.7 $ 1,230.2 $ 756.4
Net cash (used in) provided by discontinued operating activities (96.8) (43.4) (61.0)
Net cash provided by (used in) operating activities 1,180.9 1,186.8 695.4
Capital expenditures (262.6) (242.9) (179.5)
Acquisition of businesses, net of cash acquired 0 (1.9) (14.0)
Proceeds from sale of property, plant and equipment 19.2 52.0 14.5
Proceeds from business dispositions, net of cash sold 52.7 400.3 0
Dividends received from equity investments 44.3    
Net cash (used in) provided by continuing investing activities (146.4) 207.5 (179.0)
Net cash (used in) provided by discontinued investing activities 0 0 0.4
Net cash provided by (used in) investing activities (146.4) 207.5 (178.6)
Net proceeds (repayments) in debt (414.8) (54.0) (428.8)
Debt issuance costs (2.5) (2.3) (5.5)
Excess tax benefit from share based compensation 19.6 24.6 4.2
Net inter-company (payments) proceeds 0 0 0
Dividends paid to ordinary shareholders (213.1) (163.5) (110.9)
Dividends paid to noncontrolling interests (20.7) (26.2) (20.2)
Acquisition/divestiture of noncontrolling Interest (1.5) (1.3) (8.0)
Proceeds shares issued under incentive plans 152.9 109.0 145.3
Repurchase of ordinary shares (839.8) (1,157.5) 0
Other, net (4.7) (1.4) 0
Net cash (used in) provided by continuing financing activities (1,303.9) (1,246.4) (403.7)
Effect of exchange rate changes on cash and cash equivalents (9.2) (1.5) 24.5
Net (decrease) increase in cash and cash equivalents (278.6) 146.4 137.6
Cash and cash equivalents - beginning of period 1,160.7 1,014.3 876.7
Cash and cash equivalents - end of period 882.1 1,160.7 1,014.3
IR Ireland [Member]
     
Net cash (used in) provided by continuing operating activities (19.7) (13.1) 5.7
Net cash (used in) provided by discontinued operating activities 0 0 0
Net cash provided by (used in) operating activities (19.7) (13.1) 5.7
Capital expenditures 0 0 0
Acquisition of businesses, net of cash acquired 0 0 0
Proceeds from sale of property, plant and equipment 0 0 0
Proceeds from business dispositions, net of cash sold 0 0 0
Dividends received from equity investments 0    
Net cash (used in) provided by continuing investing activities 0 0 0
Net cash (used in) provided by discontinued investing activities 0 0 0
Net cash provided by (used in) investing activities 0 0 0
Net proceeds (repayments) in debt 0 0 0
Debt issuance costs 0 0 0
Excess tax benefit from share based compensation 19.6 0 0
Net inter-company (payments) proceeds 884.5 1,199.0 (60.6)
Dividends paid to ordinary shareholders (192.4) (137.3) (90.6)
Acquisition/divestiture of noncontrolling Interest (0.4) 0 0
Proceeds shares issued under incentive plans 152.9 109.0 145.3
Repurchase of ordinary shares (839.8) (1,157.5) 0
Other, net (4.7) (0.5) 0
Net cash (used in) provided by continuing financing activities 19.7 12.7 (5.9)
Effect of exchange rate changes on cash and cash equivalents 0 0 0
Net (decrease) increase in cash and cash equivalents 0 (0.4) (0.2)
Cash and cash equivalents - beginning of period 0 0.4 0.6
Cash and cash equivalents - end of period 0 0 0.4
IR Limited [Member]
     
Net cash (used in) provided by continuing operating activities (0.4) (5.3) (0.4)
Net cash (used in) provided by discontinued operating activities 0 0 0
Net cash provided by (used in) operating activities (0.4) (5.3) (0.4)
Capital expenditures 0 0 0
Acquisition of businesses, net of cash acquired 0 0 0
Proceeds from sale of property, plant and equipment 0 0 0
Proceeds from business dispositions, net of cash sold 0 0 0
Dividends received from equity investments 0    
Net cash (used in) provided by continuing investing activities 0 0 0
Net cash (used in) provided by discontinued investing activities 0 0 0
Net cash provided by (used in) investing activities 0 0 0
Net proceeds (repayments) in debt 0 0 0
Debt issuance costs 0 0 0
Excess tax benefit from share based compensation 0 0 0
Net inter-company (payments) proceeds 0.4 5.3 37.1
Dividends paid to ordinary shareholders 0 0 (36.7)
Acquisition/divestiture of noncontrolling Interest 0 0 0
Proceeds shares issued under incentive plans 0 0 0
Repurchase of ordinary shares 0 0 0
Other, net 0 0 0
Net cash (used in) provided by continuing financing activities 0.4 5.3 0.4
Effect of exchange rate changes on cash and cash equivalents 0 0 0
Net (decrease) increase in cash and cash equivalents 0 0 0
Cash and cash equivalents - beginning of period 0 0 0
Cash and cash equivalents - end of period 0 0 0
IR International [Member]
     
Net cash (used in) provided by continuing operating activities (15.1) (14.0) (15.0)
Net cash (used in) provided by discontinued operating activities 0 0 0
Net cash provided by (used in) operating activities (15.1) (14.0) (15.0)
Capital expenditures 0 0 0
Acquisition of businesses, net of cash acquired 0 0 0
Proceeds from sale of property, plant and equipment 0 0 0
Proceeds from business dispositions, net of cash sold 0 0 0
Dividends received from equity investments 0    
Net cash (used in) provided by continuing investing activities 0 0 0
Net cash (used in) provided by discontinued investing activities 0 0 0
Net cash provided by (used in) investing activities 0 0 0
Net proceeds (repayments) in debt 0 0 0
Debt issuance costs 0 0 0
Excess tax benefit from share based compensation 0 0 0
Net inter-company (payments) proceeds 15.1 2.0 27.0
Dividends paid to ordinary shareholders 0 0 0
Acquisition/divestiture of noncontrolling Interest 0 0 0
Proceeds shares issued under incentive plans 0 0 0
Repurchase of ordinary shares 0 0 0
Other, net 0 0 0
Net cash (used in) provided by continuing financing activities 15.1 2.0 27.0
Effect of exchange rate changes on cash and cash equivalents 0 0 0
Net (decrease) increase in cash and cash equivalents 0 (12.0) 12.0
Cash and cash equivalents - beginning of period 0 12.0 0
Cash and cash equivalents - end of period 0 0 12.0
IR Global Holding [Member]
     
Net cash (used in) provided by continuing operating activities (570.5) (185.3) (379.9)
Net cash (used in) provided by discontinued operating activities 0 0 0
Net cash provided by (used in) operating activities (570.5) (185.3) (379.9)
Capital expenditures 0 0 (0.3)
Acquisition of businesses, net of cash acquired 0 0 0
Proceeds from sale of property, plant and equipment 0 0 0
Proceeds from business dispositions, net of cash sold 0 0 0
Dividends received from equity investments 0    
Net cash (used in) provided by continuing investing activities 0 0 (0.3)
Net cash (used in) provided by discontinued investing activities 0 0 0
Net cash provided by (used in) investing activities 0 0 (0.3)
Net proceeds (repayments) in debt (344.5) (0.2) (249.8)
Debt issuance costs (2.5) (2.3) (5.5)
Excess tax benefit from share based compensation 0 0 0
Net inter-company (payments) proceeds 737.6 329.7 653.6
Dividends paid to ordinary shareholders 0 0 0
Acquisition/divestiture of noncontrolling Interest 0 0 0
Proceeds shares issued under incentive plans 0 0 0
Repurchase of ordinary shares 0 0 0
Other, net 0 0 0
Net cash (used in) provided by continuing financing activities 390.6 327.2 398.3
Effect of exchange rate changes on cash and cash equivalents 0 0 0
Net (decrease) increase in cash and cash equivalents (179.9) 141.9 18.1
Cash and cash equivalents - beginning of period 241.8 99.9 81.8
Cash and cash equivalents - end of period 61.9 241.8 99.9
IR New Jersey [Member]
     
Net cash (used in) provided by continuing operating activities (122.1) 143.0 (486.8)
Net cash (used in) provided by discontinued operating activities 0.3 (79.1) (16.8)
Net cash provided by (used in) operating activities (121.8) 63.9 (503.6)
Capital expenditures (74.9) (47.6) (36.3)
Acquisition of businesses, net of cash acquired 0 0 0
Proceeds from sale of property, plant and equipment 3.1 3.1 0
Proceeds from business dispositions, net of cash sold 0 0 0
Dividends received from equity investments 0    
Net cash (used in) provided by continuing investing activities (71.8) (44.5) (36.3)
Net cash (used in) provided by discontinued investing activities 0 0 0
Net cash provided by (used in) investing activities (71.8) (44.5) (36.3)
Net proceeds (repayments) in debt (9.2) (7.7) (7.8)
Debt issuance costs 0 0 0
Excess tax benefit from share based compensation 0 11.8 4.2
Net inter-company (payments) proceeds 184.1 (81.2) 503.5
Dividends paid to ordinary shareholders 0 0 0
Acquisition/divestiture of noncontrolling Interest 0 0 0
Proceeds shares issued under incentive plans 0 0 0
Repurchase of ordinary shares 0 0 0
Other, net 0 0 0
Net cash (used in) provided by continuing financing activities 174.9 (77.1) 499.9
Effect of exchange rate changes on cash and cash equivalents 0 0 0
Net (decrease) increase in cash and cash equivalents (18.7) (57.7) (40.0)
Cash and cash equivalents - beginning of period 77.8 135.5 175.5
Cash and cash equivalents - end of period 59.1 77.8 135.5
Other Subsidiaries [Member]
     
Net cash (used in) provided by continuing operating activities 2,325.0 1,326.4 1,678.6
Net cash (used in) provided by discontinued operating activities (97.1) 35.7 (44.2)
Net cash provided by (used in) operating activities 2,227.9 1,362.1 1,634.4
Capital expenditures (187.7) (195.3) (142.9)
Acquisition of businesses, net of cash acquired 0 (1.9) (14.0)
Proceeds from sale of property, plant and equipment 16.1 48.9 14.5
Proceeds from business dispositions, net of cash sold 52.7 400.3 0
Dividends received from equity investments 44.3    
Net cash (used in) provided by continuing investing activities (74.6) 252.0 (142.4)
Net cash (used in) provided by discontinued investing activities 0 0 0.4
Net cash provided by (used in) investing activities (74.6) 252.0 (142.0)
Net proceeds (repayments) in debt (61.1) (46.1) (171.2)
Debt issuance costs 0 0 0
Excess tax benefit from share based compensation 0 12.8 0
Net inter-company (payments) proceeds (1,821.7) (1,454.8) (1,160.6)
Dividends paid to ordinary shareholders (340.2) (47.7) (29.4)
Acquisition/divestiture of noncontrolling Interest (1.1) (1.3) (8.0)
Proceeds shares issued under incentive plans 0 0 0
Repurchase of ordinary shares 0 0 0
Other, net 0 (0.9) 0
Net cash (used in) provided by continuing financing activities (2,224.1) (1,538.0) (1,369.2)
Effect of exchange rate changes on cash and cash equivalents (9.2) (1.5) 24.5
Net (decrease) increase in cash and cash equivalents (80.0) 74.6 147.7
Cash and cash equivalents - beginning of period 841.1 766.5 618.8
Cash and cash equivalents - end of period 761.1 841.1 766.5
Consolidating Adjustments [Member]
     
Net cash (used in) provided by continuing operating activities (319.5) (21.5) (45.8)
Net cash (used in) provided by discontinued operating activities 0 0 0
Net cash provided by (used in) operating activities (319.5) (21.5) (45.8)
Capital expenditures 0 0 0
Acquisition of businesses, net of cash acquired 0 0 0
Proceeds from sale of property, plant and equipment 0 0 0
Proceeds from business dispositions, net of cash sold 0 0 0
Dividends received from equity investments 0    
Net cash (used in) provided by continuing investing activities 0 0 0
Net cash (used in) provided by discontinued investing activities 0 0 0
Net cash provided by (used in) investing activities 0 0 0
Net proceeds (repayments) in debt 0 0 0
Debt issuance costs 0 0 0
Excess tax benefit from share based compensation 0 0 0
Net inter-company (payments) proceeds 0 0 0
Dividends paid to ordinary shareholders 319.5 21.5 45.8
Acquisition/divestiture of noncontrolling Interest 0 0 0
Proceeds shares issued under incentive plans 0 0 0
Repurchase of ordinary shares 0 0 0
Other, net 0 0 0
Net cash (used in) provided by continuing financing activities 319.5 21.5 45.8
Effect of exchange rate changes on cash and cash equivalents 0 0 0
Net (decrease) increase in cash and cash equivalents 0 0 0
Cash and cash equivalents - beginning of period 0 0 0
Cash and cash equivalents - end of period $ 0 $ 0 $ 0